These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28404622)

  • 1. Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts.
    Iqbal J; Kwok CS; Kontopantelis E; de Belder MA; Ludman PF; Large A; Butler R; Gamal A; Kinnaird T; Zaman A; Mamas MA;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
    Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.
    Aggarwal V; Stanislawski MA; Maddox TM; Nallamothu BK; Grunwald G; Adams JC; Ho PM; Rao SV; Casserly IP; Rumsfeld JS; Brilakis ES; Tsai TT
    J Am Coll Cardiol; 2014 Oct; 64(17):1825-36. PubMed ID: 25443706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
    Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
    Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
    Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-generation drug eluting stent vs. bare metal stent in saphenous vein graft - 1 year outcomes by a propensity score ascertainment (SVG Baltic Registry).
    Wańha W; Mielczarek M; Roleder T; Ładziński S; Milewski M; Gilis-Malinowska N; Chmielecki M; Ciećwierz D; Bachorski W; Kunik P; Trznadel A; Męcka K; Genc A; Januszek R; Pączek P; Dziewierz A; Bartuś S; Gruchała M; Smolka G; Dudek D; Navarese EP; Ochała A; Jaguszewski M; Wojakowski W
    Int J Cardiol; 2019 Oct; 292():56-61. PubMed ID: 31003797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials.
    Nairooz R; Saad M; Dhillon AS; Yousaf H; Awar L; Mehra A; Matthews RV; Shavelle D; Clavijo L
    Cardiovasc Revasc Med; 2018 Dec; 19(8):951-955. PubMed ID: 30078629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention.
    Patel NJ; Bavishi C; Atti V; Tripathi A; Nalluri N; Cohen MG; Kini AS; Sharma SK; Dangas G; Bhatt DL
    Circ Cardiovasc Interv; 2018 Nov; 11(11):e007045. PubMed ID: 30571204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The short- and long-term outcomes of percutaneous intervention with drug-eluting stent vs bare-metal stent in saphenous vein graft disease: An updated meta-analysis of all randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Ahmed S; Bachuwa G; Hassan M
    Clin Cardiol; 2018 May; 41(5):685-692. PubMed ID: 29749621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis.
    Mosleh W; Gandhi S; Elsiddig M; Schwalm JD; Farkouh ME
    J Invasive Cardiol; 2016 Dec; 28(12):E139-E169. PubMed ID: 27845875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.
    Pokala NR; Menon RV; Patel SM; Christopoulos G; Christakopoulos GE; Kotsia AP; Rangan BV; Roesle M; Abdullah S; Grodin J; Kumbhani DJ; Hastings J; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):34-40. PubMed ID: 26033073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial.
    Brilakis ES; Banerjee S; Edson R; Shunk K; Goldman S; Holmes DR; Bhatt DL; Rao SV; Smith MW; Sather M; Colling C; Kar B; Nielsen L; Conner T; Wagner T; Rangan BV; Ventura B; Lu Y; Holodniy M; Shih MC
    Clin Cardiol; 2017 Nov; 40(11):946-954. PubMed ID: 28841230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions.
    Assali A; Raz Y; Vaknin-Assa H; Ben-Dor I; Brosh D; Teplitsky I; Fuchs S; Kornowski R
    EuroIntervention; 2008 May; 4(1):108-14. PubMed ID: 19112787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009).
    Brennan JM; Sketch MH; Dai D; Trilesskaya M; Al-Hejily W; Rao SV; Brilakis E; Messenger JC; Shaw RE; Anstrom KJ; Peterson ED; Douglas PS
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):43-9. PubMed ID: 26153480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts.
    Lee MS; Shah AP; Aragon J; Jamali A; Dohad S; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):507-11. PubMed ID: 16270361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts.
    Nauta ST; Van Mieghem NM; Magro M; Deckers JW; Simsek C; Van Geuns RJ; Van Der Giessen WJ; De Jaegere P; Regar E; Van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2012 May; 79(6):912-8. PubMed ID: 21542111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study.
    Pasceri V; Tarsia G; Niccoli G; Viceconte N; Porto I; Leone AM; Trani C; Speciale G; Lisanti P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1112-7. PubMed ID: 22422701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.